Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/05/2009CN100522208C Damp dispelling and pain relieving externally applied medicine and its preparing method
08/05/2009CN100522197C Chinese-medicinal preparation for treating high blood fat and its making method
08/05/2009CN100522195C Medicine composition for treating cardiovascular and cerebrovascular diseases, preparation method and use thereof
08/05/2009CN100522194C Traditional Chinese medicine for treating oral paralysis and preparing process thereof
08/05/2009CN100522186C Sustained release capsules of ginkgo leaf and preparation method
08/05/2009CN100522182C Vitamin microelement mineral calcium nutritire product for preventing and treating nightblindness and its manufacturing method
08/05/2009CN100522179C Medicine composition for treating cardiovascular and cerebrovascular disease and its preparation method
08/05/2009CN100522178C Formulations useful in the treatment of male and female impotence
08/05/2009CN100522177C Application of gastrodin in the medicine for treating rheumatoid arthritis
08/05/2009CN100522176C Medicine composition for treating vaginal diseases
08/05/2009CN100522175C Sustained release tablet of oleanolic acid and its preparation method
08/05/2009CN100522174C Crystalline isoxazole derivative and medical preparation thereof
08/05/2009CN100522173C Pharmaceutical composition containing pemetrexed
08/05/2009CN100522172C Non-sedating barbiturate compounds as neuroprotective agents
08/05/2009CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
08/05/2009CN100522170C Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia
08/05/2009CN100522169C Ranolazine hydrochloride slow-release preparation and its preparing method
08/05/2009CN100522168C Sustained releasing capsule of rotundine and its preparation method
08/05/2009CN100522167C Palonosetron injection and its powder injection preparation of salt receptable on medicine and its preparing method
08/05/2009CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
08/05/2009CN100522165C Lansoprazole intestine solution capsule and its preparation method
08/05/2009CN100522164C Method of treating of demyelinating diseases or conditions
08/05/2009CN100522163C Small volume vincamine injection and its preparation process
08/05/2009CN100522162C New pranoprofen eye drops and its preparation method
08/05/2009CN100522161C (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
08/05/2009CN100522160C Application of indole-2, 3-diketone in preparing antimycotics medicament
08/05/2009CN100522159C The use of substituted azetidinone compounds for the treatment of sitosterolemia
08/05/2009CN100522158C Application of Gulunbin, iso-gulunbin and fibleucin for preparing medicine for treating arthritis
08/05/2009CN100522157C Treatment of diseases involving defective gap junctional communication
08/05/2009CN100522156C Tanshinone IIA sodium sulfonate transfusion liquid, its preparation method and photophobic outer package
08/05/2009CN100522155C Use of retigabin for treating neuropathic pain
08/05/2009CN100522154C Use of isothiocyanates compound for treatment of helicobacter
08/05/2009CN100522153C Application of carbonyl scavengers for preparing medicament for inducing or increasing cell death
08/05/2009CN100522152C Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
08/05/2009CN100522151C Compounds for treatment of inflammation, diabetes and related disorders
08/05/2009CN100522150C Angiogenesis inhibitor
08/05/2009CN100522149C Novel application of peptide class of compound for treating allodynia or other different types of chronic or phantom pain
08/05/2009CN100522148C Inclusion cyclodextrin/vanillin ex polar bear medicinal composition and its preparing method
08/05/2009CN100522147C Application of 5, 6, 7-tri-hydroxy enanthic acid and analog thereof for treating dry eye disorders and uveitis
08/05/2009CN100522137C Cream for treating psoriasis and its preparing process
08/05/2009CN100522135C Inhalation kit comprisung inhalable powder of tiotropium
08/05/2009CN100521972C Composition for promotion of bone growth and maintenance of bone health
08/05/2009CN100521962C Process for producing lacturose-containing powder composition, lacturose-containing powder composition obtained by the process and feed additive
08/04/2009US7569729 Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
08/04/2009US7569726 Indanone derivatives that inhibit prolyl hydroxylase
08/04/2009US7569725 2-[(3-chloro-4-hydroxybenzoyl)amino]-N-[2-(2-methoxyphenyl)ethyl]-5-phenoxybenzamide; therapeutic use as anti-cancer agents, as well as other therapeutic agents, for example, as anti-fertility agents
08/04/2009US7569724 Antiproliferative agnets; anticancer agents; skin disorders
08/04/2009US7569723 HIV antiviral agents; 2-((p-carboxyphenyl)aminocarbonylmethoxy)-5-halo-benzophenone compounds
08/04/2009US7569711 Enone cancer therapeutics
08/04/2009US7569702 Iodinating a 4-nitroimidazole compound substituted with a chlorine atom or bromine atom, and then reducing the obtained 5-iodo-4-nitroimidazole compound; high yield and high purity; safe method causing few dangers such as explosion
08/04/2009US7569701 Crystal form of 5-hydroxy-1-methylimidazolidin-2,4-dione
08/04/2009US7569700 Substituted, bicyclic 8-pyrrolidinobenzimidazoles, methods for their production and their use as medicaments
08/04/2009US7569698 Process for the isolation and purification of epothilones
08/04/2009US7569697 Benzimidazole compound crystal
08/04/2009US7569696 Process for producing crystal
08/04/2009US7569689 Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
08/04/2009US7569688 Propane-1, 3-dione derivative
08/04/2009US7569666 Polypeptides associated with activatory receptors and their biological applications
08/04/2009US7569612 hypercholesterolemia or mixed hyperlipidemia, administering an immediate release dosage of this fenofibrate metabolite without regard to meals
08/04/2009US7569611 Storage stability; combination forms with antidepressants, antiinflammatories, serotonin reuptake inhibitors, antiemetics, appetite modulators, antivirals, vasodilators and/or pain relievers
08/04/2009US7569610 Administering bupropion hydrobromide to treat seasonal affective, obsessive compulsive, post-traumatic stress, psychological, respiratory system, attention deficit/hyperactivity, sexual or sleep disorders; anxiolytic agents, antidepressants; neurpathic pain, fibromyalgia, viricides; headaches, obesity
08/04/2009US7569609 Treating Alzheimer's disease with 2-propylpentanoic acid (valproic acid) or salts thereof; improving the GABAA receptor responses
08/04/2009US7569608 Pentanoic acid derivatives
08/04/2009US7569606 Platinum complexes with mononitrile-containing ligands
08/04/2009US7569605 Synergistic effect; anxiety disorders, depression
08/04/2009US7569604 Heterocyclic derivatives for modulation of calcium channels
08/04/2009US7569602 [(Alkyl-phenyl-furan-3-carbonyl)-amino]-phenyl-acetic acids; for treatment of headaches and migraines
08/04/2009US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis
08/04/2009US7569600 5-Cyclohex-1-enyl-3-[(trans-4-hydroxy-cyclohexyl)-cyclohexyl)-(trans-4-methyl-cyclohexanecarbonyl)-amino]-thiophene-2-carboxylic acid
08/04/2009US7569599 Reacting alkylsulfonyl chloride in presence of base, cyanating, deblocking
08/04/2009US7569598 Isomerization; crystallization
08/04/2009US7569597 Isoindoline compounds and methods of their use
08/04/2009US7569596 e.g. N1-[(E)-1-(4-fluorophenyl)methylidene]-4-(1,3-thiazol-2-yl)-1H-1,2-imidazolediamine; anticarcinogenic agent; sid effect reduction
08/04/2009US7569595 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion
08/04/2009US7569594 antiproliferative agents; cancer
08/04/2009US7569593 Compounds and compositions as protein kinase inhibitors
08/04/2009US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
08/04/2009US7569591 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals
08/04/2009US7569590 Use of thianecarboxamides as dgat inhibitors
08/04/2009US7569589 (R)-N-{6-[1-(4-fluorophenyl)-2,2-dipyridin-3-ylethyl]pyridin-2-yl}methanesulfonamide; cardiac arrhythmias
08/04/2009US7569588 Biphenyl compounds useful as muscarinic receptor antagonists
08/04/2009US7569587 Such as 14-O[(N-(3-Methyl-2-amino-buturyl-piperidin-3(S)-yl)sulfanyl)acetyl]mutilin
08/04/2009US7569586 Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
08/04/2009US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease
08/04/2009US7569584 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same
08/04/2009US7569583 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
08/04/2009US7569581 Anticholinergics which may be used as medicaments as well as processes for preparing them
08/04/2009US7569580 Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid
08/04/2009US7569579 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome
08/04/2009US7569578 Heterocyclic anti-migraine agents
08/04/2009US7569577 (2S)-1-[4-({4-[3-chloro-2-fluoroanilino]-6-methoxyquinazolin-7-yl}oxy)piperidin-1-yl]-1-oxopropan-2-ol; antiproliferative agents; for treatment of cancers mediated by erbB receptor EGFR tyrosine kinases; psoriasis
08/04/2009US7569576 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
08/04/2009US7569575 Synthesis of locked nucleic acid derivatives
08/04/2009US7569574 Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
08/04/2009US7569573 Nucleobase substituted with a 2-hydroxy-4-oxobut-2-enoic acid or ester or a 1-hydroxy-3-oxopropenephosphonic acid or ester, e.g., Methyl 4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoate
08/04/2009US7569572 Such as 2-dimethylamino-N-[5-dimethylamino-1-(2-ethoxyethyl)-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-3-ylmethyl]acetamide; cyclic-gmp phosphodiesterase/3*,5*-/ inhibitors
08/04/2009US7569571 Such as N-cyclopropyl-4-methyl-3-(4-phenyl-pyrazolo[3,4-d]pyrimidin-1-yl)-benzamide; for inhibiting p38 kinase mediated diseases and disorders such as inflammatory diseases
08/04/2009US7569570 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone
08/04/2009US7569569 Pyrrolo[2,3-d]pyrimidine compounds
08/04/2009US7569568 1-[5-(5-tert-Butyl-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; inflammation, chronic inflammatory disease
1 ... 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 ... 7860